{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:26:52Z","timestamp":1778887612474,"version":"3.51.4"},"reference-count":24,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,9,10]],"date-time":"2009-09-10T00:00:00Z","timestamp":1252540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Cutaneous leishmaniasis (CL) is a disease caused by leishmania species. Intralesional sodium stibogluconate (SSG) has been considered the first line therapy for localized cutaneous leishmaniasis. There is still a need for more effective and less time\u2010consuming therapeutic methods for this condition.<\/jats:p><jats:p><jats:bold>Objective\u2002<\/jats:bold> The aim of the present study was to investigate if the combination of intramuscular (IM) SSG or oral ketoconazole with intralesional (IL) SSG would be more effective than the intralesional SSG given alone in the treatment of localized cutaneous leishmaniasis.<\/jats:p><jats:p><jats:bold>Patients and methods\u2002<\/jats:bold> Thirty patients with confirmed diagnosis of cutaneous leishmaniasis were included in the study. They were randomly assigned to three groups. The first group (10 patients with 12 lesions) was treated with intralesional SSG alone. The second group (10 patients with 15 lesions) was treated with the combination of intralesional SSG + intramuscular SSG. The third group (10 patients with 13 lesions) was treated with the combination of intralesional SSG and oral ketoconazole. A follow\u2010up was performed every 4\u2003weeks for a treatment period of 12\u2003weeks, then monthly for a period of 6\u2003months after the end of the treatment.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Complete cure occurred in 58.3% of lesions in group 1, while 93.3% and 92.3% of lesions were cured in group 2 and 3 respectively. The difference between group 1 and the other groups was statistically significant (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05).<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> Combined intramuscular SSG or oral ketoconazole with intralesional SSG is more effective than intralesional SSG alone for the treatment of CL. Oral ketoconazole is much easier and safer therapy than intramuscular SSG in combination with intralesional SSG in the treatment of localized cutaneous leishmaniasis.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2009.03417.x","type":"journal-article","created":{"date-parts":[[2009,9,11]],"date-time":"2009-09-11T03:27:42Z","timestamp":1252639662000},"page":"335-340","source":"Crossref","is-referenced-by-count":30,"title":["Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study"],"prefix":"10.1111","volume":"24","author":[{"given":"M","family":"El\u2010Sayed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AE","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,2,8]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2004.01605.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0738-081X(96)00058-2"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630601159474"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1996.tb03669.x"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.33651"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.01991.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)80121-6"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02002.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1999.00769.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1992.46.296"},{"key":"e_1_2_5_12_2","first-page":"66","volume-title":"Control of Leishmaniasis","author":"World Health organization","year":"1990"},{"key":"e_1_2_5_13_2","first-page":"170","article-title":"A new focus of cutaneous leishmaniasis in Himachal Pradesh (India)","volume":"69","author":"Sharma RC","year":"2003","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_5_14_2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.4269\/ajtmh.2005.72.819","article-title":"Localized cutaneous leishmaniasis due to Leishmania donovani and Leishmania tropica preliminary findings of the study of 161 new cases from a new endemic focus in himachal pradesh, India","volume":"72","author":"Sharma NL","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1988.tb07100.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1985.34.702"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.5.878"},{"key":"e_1_2_5_18_2","first-page":"310","article-title":"Hypoplasia of bone marrow secondary to sodium antimony gluconate","volume":"38","author":"Mallick BK","year":"1990","journal-title":"J Assoc Physicians India"},{"key":"e_1_2_5_19_2","first-page":"383","article-title":"Renal dysfunction in patients of kala azar treated with sodium antimony gluconate","volume":"42","author":"Rai US","year":"1994","journal-title":"J Assoc Physicians India"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/clind\/24.4.684"},{"key":"e_1_2_5_21_2","first-page":"596","article-title":"Ketoconazole in cutaneous leishmaniasis Results of a pilot study","volume":"7","author":"Kubba R","year":"1986","journal-title":"Saudi Med J"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/2.4.520"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1982.tb03163.x"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.35750"},{"key":"e_1_2_5_25_2","first-page":"612.1","volume-title":"Recent Advances in Chemotherapy, Antimicrobial (Section 2)","author":"DeBeule K","year":"1989"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2009.03417.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2009.03417.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T05:57:19Z","timestamp":1697349439000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2009.03417.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,8]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1468-3083.2009.03417.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03417.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,8]]}}}